4//SEC Filing
KAY CHRISTINA 4
Accession 0001345281-25-000003
CIK 0001016504other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:56 PM ET
Size
7.4 KB
Accession
0001345281-25-000003
Insider Transaction Report
Form 4
KAY CHRISTINA
DirectorExecutive Vice President
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2025-05-21−144,445→ 0 totalExercise: $0.09Exp: 2025-06-02→ Common Stock (144,445 underlying) - Award
Common Stock
2025-05-21$0.09/sh+144,445$13,000→ 1,473,467 total
Footnotes (2)
- [F1]144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
- [F2]81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
Related Parties
1- filerCIK 0001064901
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:56 PM ET
- Size
- 7.4 KB